This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Diane Nepomuceno: Innovator in Canine Receptor Research
Introduction
Diane Nepomuceno is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmacology, particularly in the study of canine receptors. Her work focuses on the 5-hydroxytryptamine (5-HT) receptor, which plays a crucial role in various physiological processes.
Latest Patents
Diane holds a patent for "Canine 5-hydroxytryptamine 2A and 2B receptor." This patent describes materials including polypeptides corresponding to SEQ ID NOs.:8 and 10, as well as polynucleotides expressing them corresponding to SEQ ID NOs.:7 and 9. These materials are valuable as reagents in drug screening assays aimed at identifying compounds with 5-HT receptor-modulating activity. She has 1 patent to her name.
Career Highlights
Diane is currently associated with Janssen Pharmaceutica NV, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of canine receptors and their potential applications in drug discovery.
Collaborations
Diane collaborates with notable colleagues such as Pascal Bonaventure and Changlu Liu. Their combined expertise enhances the research efforts at Janssen Pharmaceutica NV.
Conclusion
Diane Nepomuceno's innovative work in canine receptor research exemplifies her commitment to advancing pharmacological science. Her contributions are paving the way for new discoveries in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile